ORAMED PHARMACEUTICALS INC. (ORMP) has 39 open-market insider trades by 14 insiders since 2007. The most active filer is Nadav Kidron, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Nadav Kidron | CEOPres | — | 7 | $4.9M | 2026-09-24 |
| Miriam Kidron | CSO | — | 6 | $4.2M | 2026-09-24 |
| Fund Lp Regals | 10% | — | 2 | $1.6M | 2014-03-25 |
| Xiaopeng Li | Dir | — | 2 | $1.4M | 2017-08-02 |
| Kevin Rakin | Dir | — | 2 | $980K | 2022-03-21 |
| Leonard Sank | Dir | — | 7 | $359K | 2025-06-05 |
| Yadin Rozov | Dir | — | 1 | $244K | 2024-01-04 |
| Michael Rabinowitz | CCO | — | 1 | $149K | 2023-01-03 |
| Michael Berelowitz | Dir | — | 3 | $117K | 2015-12-09 |
| Arie Mayer | Dir | — | 2 | $96K | 2025-12-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Avraham Gabay | CFO | Sell | $90K | 2026-10-01 |
| Joshua Hexter | COO | Sell | $135K | 2026-10-01 |
| Joshua Hexter | COO | Sell | $611K | 2026-07-01 |
| Avraham Gabay | CFO | Sell | $331K | 2026-07-01 |
| Arie Mayer | Director | Buy | $20K | 2023-04-03 |
| Nadav Kidron | CEO & President | Buy | $53K | 2023-03-16 |
Companies that share insiders with ORMP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Miriam Kidron | CSO | Sell | $402K | 2023-03-14 |
| Yadin Rozov | Director | Buy | $244K | 2023-03-13 |
| Michael Rabinowitz | CCO | Sell | $167K | 2023-01-03 |
| Kevin Rakin | Director | Sell | $94K | 2022-03-21 |
| Arie Mayer | Director | Sell | $77K | 2021-11-01 |
| Kevin Rakin | Director | Sell | $886K | 2021-09-16 |
| Nadav Kidron | CEO & President | Sell | $4.4M | 2021-08-09 |
| Leonard Sank | Director | Buy | $73K | 2019-09-09 |
| Leonard Sank | Director | Buy | $196K | 2019-07-16 |